The cost-effectiveness of aspirin for chemoprevention of colorectal cancer

Gastroenterology. 2002 Jan;122(1):230-3. doi: 10.1053/gast.2002.30618.
No abstract available

Publication types

  • Comment
  • Editorial
  • Review

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / economics
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Aspirin / economics
  • Aspirin / therapeutic use*
  • Colorectal Neoplasms* / drug therapy
  • Colorectal Neoplasms* / economics
  • Colorectal Neoplasms* / prevention & control
  • Cost-Benefit Analysis
  • Humans

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Aspirin